SCHEMBL633346

SCHEMBL633346

NC(Cc1c[nH]cn1)c1ccc(Cl)c(F)c1

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 4/20 0.33
S1PR1 P21453 1/20 0.33
S1PR3 Q99500 1/20 0.33
SLC6A2 P23975 8/20 0.32
SLC6A4 P31645 8/20 0.32
SLC6A3 Q01959 8/20 0.32
CYP1A2 P05177 4/20 0.32
CYP3A4 P08684 4/20 0.32
CYP2D6 P10635 4/20 0.32
CYP2C9 P11712 4/20 0.32
CYP2C19 P33261 4/20 0.32
RPS6KB1 P23443 2/20 0.32
GPR139 Q6DWJ6 1/20 0.32
KCNH2 Q12809 3/20 0.32
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL632706 0.89 DPP4 (0.36) DPP4SLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL632482 0.87 DPP4 (0.37) DPP4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL632202 0.87 PNMT (0.35) SLC6A2SLC6A4SLC6A3CYP3A4CYP2D6
SCHEMBL633294 0.81 DPP4 (0.39) DPP4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL632963 0.81 DYRK1A (0.36) CYP1A2CYP2D6CYP2C9CYP2C19GRIN1
SCHEMBL633241 0.80 GRIN2D (0.39) DPP4CYP1A2CYP2D6CYP2C19GRIN2D
SCHEMBL631846 0.77 GRIN2D (0.33) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL632193 0.77 GRIN2D (0.33) DPP4GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL632350 0.77 DPP4 (0.32) DPP4
SCHEMBL633165 0.74 DPP4 (0.41) DPP4CYP1A2CYP2D6CYP2C19GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8586617-B2 Aminomethyl-4-imidazoles HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2076497-B1 AMINOMETHYL-4-IMIDAZOLES HOFFMANN LA ROCHE (CH) 2012-02-22 EP disclosed
EP-2076497-A1 AMINOMETHYL-4-IMIDAZOLES F. Hoffmann-Roche AG (CH) 2009-07-08 EP disclosed
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-05-22 US disclosed
WO-2008046757-A1 AMINOMETHYL-4-IMIDAZOLES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119535-A1 AMINOMETHYL-4-IMIDAZOLES INMT, HTR4, MC4R DPP4 67/4885S1PR1 3965/4885S1PR3 3880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.